Article: GlaxoSmithKline Renews BioExpress Subscription with Gene Logic; Continues Use of Comprehensive Gene Expression Tool Begun in Late 2001.

Business Editors/Health/Medical Writers

BIOWIRE2K

GAITHERSBURG, Md.--(BUSINESS WIRE)--Dec. 22, 2003

Gene Logic Inc. (Nasdaq:GLGC) today announced that GlaxoSmithKline (NYSE:GSK) (GSK), a leading global pharmaceutical company, has renewed its subscription to Gene Logic's BioExpress(TM) System for use in GSK's primary discovery initiatives. Financial details of the two-year renewal agreement were not disclosed.

Gene Logic Overview

Gene Logic is a contract ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!